Notes
International Classification of Diseases-10
References
1. Tanaka E, et al. Medical Cost and Resource use in Patients Starting Treatment for Rheumatoid Arthritis Treated with and Without Corticosteroids in Japan. 22nd Annual Congress of the European League Against Rheumatism : abstr. POS0554, 2 Jun 2021. Available from: URL: http://scientific.sparx-ip.net/archiveeular/index.cfm?c=a&view=2&item=2021POS0554
2. Tanaka E, et al. Medical Costs for Patients Starting Treatment for Rheumatoid Arthritis Who Have Comorbid Diabetes Mellitus in Japan. 22nd Annual Congress of the European League Against Rheumatism : abstr. POS0551, 2 Jun 2021. Available from: URL: http://scientific.sparx-ip.net/archiveeular/index.cfm?c=a&view=2&item=2021POS0551
Rights and permissions
About this article
Cite this article
Medical costs higher for RA patients receiving corticosteroids and those with DM in Japan. PharmacoEcon Outcomes News 882, 20 (2021). https://doi.org/10.1007/s40274-021-7854-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7854-1